Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2010 2
2011 4
2012 4
2013 3
2014 4
2015 3
2016 5
2017 3
2018 11
2019 12
2020 20
2021 25
2022 26
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party.
Penack O, Tridello G, Salmenniemi U, Martino R, Khanna N, Perruccio K, Fagioli F, Richert-Przygonska M, Labussière-Wallet H, Maertens J, Jubert C, Aljurf M, Pichler H, Kriván G, Kunadt D, Popova M, Gabriel M, Calore E, Blau IW, Benedetti F, Itäla-Remes M, de Kort E, Russo D, Faraci M, Ménard AL, Borne PVD, Poiré X, Yesilipek A, Gozdzik J, Yeğin ZA, Yañez L, Facchini L, Van Gorkom G, Thurner L, Kocak U, Sampol A, Zuckerman T, Bierings M, Mielke S, Ciceri F, Wendel L, Knelange N, Mikulska M, Averbuch D, Styczynski J, Camara R, Cesaro S. Penack O, et al. Among authors: thurner l. EClinicalMedicine. 2023 Dec 22;67:102393. doi: 10.1016/j.eclinm.2023.102393. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38152413 Free PMC article.
SYNCHRONOUS DIAGNOSIS OF TESTICULAR AND THYROID CANCER IN A YOUNG MALE.
Tsoukalas N, Kiakou M, Tolia M, Galanopoulos M, Tsapakidis K, Arvanitou E, Charalambakis N, Tountziaris V, Nikolaou M, Christofyllakis C. Tsoukalas N, et al. Exp Oncol. 2023 Oct 11;45(2):263-268. doi: 10.15407/exp-oncology.2023.02.263. Exp Oncol. 2023. PMID: 37824765
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies.
Christofyllakis K, Neumann F, Bewarder M, Thurner L, Kaddu-Mulindwa D, Kos IA, Lesan V, Bittenbring JT. Christofyllakis K, et al. Among authors: bittenbring jt, bewarder m, thurner l. Nutrients. 2023 Aug 8;15(16):3498. doi: 10.3390/nu15163498. Nutrients. 2023. PMID: 37630689 Free PMC article.
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis.
Fischer L, Jiang L, Bittenbring JT, Huebel K, Schmidt C, Duell J, Metzner B, Krauter J, Glass B, Huettmann A, Schaefer-Eckart K, Silkenstedt E, Klapper W, Hiddemann W, Unterhalt M, Dreyling M, Hoster E; German Lymphoma Alliance (GLA) and the German Low-Grade Lymphoma Study Group (GLSG). Fischer L, et al. Among authors: bittenbring jt. Ann Hematol. 2023 Oct;102(10):2791-2801. doi: 10.1007/s00277-023-05385-1. Epub 2023 Aug 8. Ann Hematol. 2023. PMID: 37552322 Free PMC article.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Thurner L, Ziepert M, Berdel C, Schmidt C, Borchmann P, Kaddu-Mulindwa D, Viardot A, Witzens-Harig M, Dierlamm J, Haenel M, Metzner B, Wulf G, Lengfelder E, Keller UB, Frickhofen N, Nickelsen M, Gaska T, Griesinger F, Mahlberg R, Marks R, Shpilberg O, Lindemann HW, Soekler M, Fischer von Weikersthal L, Kiehl M, Roemer E, Bentz M, Krammer-Steiner B, Trappe R, de Nully Brown P, Federico M, Merli F, Engelhard M, Glass B, Schmitz N, Truemper L, Bewarder M, Hartmann F, Murawski N, Stilgenbauer S, Rosenwald A, Altmann B, Schmidberger H, Fleckenstein J, Loeffler M, Poeschel V, Held G. Thurner L, et al. Among authors: bewarder m. Hemasphere. 2023 Jul 5;7(7):e904. doi: 10.1097/HS9.0000000000000904. eCollection 2023 Jul. Hemasphere. 2023. PMID: 37427146 Free PMC article.
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Held G, Thurner L, Poeschel V, Ott G, Schmidt C, Christofyllakis K, Viardot A, Borchmann P, Engel-Riedel W, Frickhofen N, Nickelsen M, Shpilberg O, Witzens-Harig M, Griesinger F, Krammer-Steiner B, Neubauer A, de Nully Brown P, Federico M, Glass B, Schmitz N, Wulf G, Truemper L, Bewarder M, Murawski N, Stilgenbauer S, Rosenwald A, Altmann B, Engelhard M, Schmidberger H, Fleckenstein J, Berdel C, Loeffler M, Ziepert M. Held G, et al. Among authors: bewarder m, thurner l. Hemasphere. 2023 Jul 5;7(7):e917. doi: 10.1097/HS9.0000000000000917. eCollection 2023 Jul. Hemasphere. 2023. PMID: 37427145 Free PMC article.
KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell Transplantation.
Gowdavally S, Tsamadou C, Platzbecker U, Sala E, Valerius T, Klein S, Kröger N, Wulf G, Einsele H, Thurner L, Schaefer-Eckart K, Freitag S, Casper J, Dürholt M, Kaufmann M, Hertenstein B, Ringhoffer M, Schmeller S, Neuchel C, Rode I, Amann EM, Richter A, Schrezenmeier H, Mytilineos J, Fuerst D. Gowdavally S, et al. Among authors: thurner l. Transplant Cell Ther. 2023 Jul;29(7):457.e1-457.e10. doi: 10.1016/j.jtct.2023.04.006. Epub 2023 May 6. Transplant Cell Ther. 2023. PMID: 37150297
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.
Thurner L, Fadle N, Regitz E, Roth S, Cetin O, Kos IA, Hess SM, Bein J, Bohle RM, Vornanen M, Sundström C, De Leval L, Tiacci E, Borchmann P, Engert A, Poeschel V, Held G, Schwarz EC, Neumann F, Preuss KD, Hoth M, Küppers R, Lehman K, Hansmann ML, Becker SL, Bewarder M, Hartmann S. Thurner L, et al. Among authors: bewarder m. Haematologica. 2023 Dec 1;108(12):3347-3358. doi: 10.3324/haematol.2023.282698. Haematologica. 2023. PMID: 37139600 Free PMC article.
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study.
Gagelmann N, Eikema DJ, Koster L, Netelenbos T, McDonald A, Stoppa AM, Fenk R, Anagnostopoulos A, van Gorkom G, Deconinck E, Bulabois CE, Delforge M, Bunjes D, Arcese W, Reményi P, Itälä-Remes M, Thurner L, Bolaman AZ, Nabil Y, Lund J, Labussière-Wallet H, Hayden PJ, Beksac M, Schönland S, Yakoub-Agha I. Gagelmann N, et al. Among authors: thurner l. Eur J Haematol. 2023 Aug;111(2):181-190. doi: 10.1111/ejh.13981. Epub 2023 Apr 21. Eur J Haematol. 2023. PMID: 37082839
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.
Kiefer M, Thurner L, Bock T, Cetin O, Kos I, Lesan V, Kaddu-Mulindwa D, Bittenbring JT, Fadle N, Regitz E, Hoth M, Neumann F, Preuss KD, Pfreundschuh M, Christofyllakis K, Bewarder M. Kiefer M, et al. Among authors: bittenbring jt, bewarder m, thurner l. EJHaem. 2022 Dec 27;4(1):125-134. doi: 10.1002/jha2.635. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819155 Free PMC article.
Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP.
Bewarder M, Kaddu-Mulindwa D, Kos IA, Lesan V, Held G, Poeschel V, Thurner L, Bittenbring JT, Schmitz N, Truemper L, Pfreundschuh M, Christofyllakis K, Loeffler M, Altmann B, Ziepert M. Bewarder M, et al. Among authors: bittenbring jt, thurner l. Haematologica. 2023 Oct 1;108(10):2844-2849. doi: 10.3324/haematol.2022.282126. Haematologica. 2023. PMID: 36815369 Free PMC article. No abstract available.
Autoantibodies against SUMO1-DHX35 in long-COVID.
Thurner L, Fadle N, Regitz E, Preuss KD, Neumann F, Cetin O, Schormann C, Hoffmann MC, Herr C, Kheiroddin P, Rixecker TM, Bals R, Muller S, Thurner B, Kessel C, Kabesch M, Bewarder M, Heyne K, Lensch C, Kos IA. Thurner L, et al. Among authors: bewarder m. J Transl Autoimmun. 2022 Nov 20;5:100171. doi: 10.1016/j.jtauto.2022.100171. eCollection 2022. J Transl Autoimmun. 2022. PMID: 36425003 Free PMC article.
Aberrant Naive CD4-Positive T Cell Differentiation in Systemic Juvenile Idiopathic Arthritis Committed to B Cell Help.
Kuehn J, Schleifenbaum S, Hendling M, Siebenhandl S, Krainer J, Fuehner S, Hellige A, Park C, Hinze C, Wittkowski H, Holzinger D, Thurner L, Weinhäusel A, Foell D, Kessel C. Kuehn J, et al. Among authors: thurner l. Arthritis Rheumatol. 2023 May;75(5):826-841. doi: 10.1002/art.42409. Epub 2023 Mar 17. Arthritis Rheumatol. 2023. PMID: 36409585
TREM2 Is Associated with Advanced Stages and Inferior Prognosis in Oral Squamous Cell Carcinoma.
Struckmeier AK, Radermacher A, Fehrenz M, Alansary D, Wartenberg P, Wagner M, Scheller A, Hess J, Moratin J, Freudlsperger C, Hoffmann J, Thurner L, Roemer K, Freier K, Horn D. Struckmeier AK, et al. Among authors: thurner l. Cancers (Basel). 2022 Sep 24;14(19):4635. doi: 10.3390/cancers14194635. Cancers (Basel). 2022. PMID: 36230558 Free PMC article.
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
Thurner L, Kessel C, Fadle N, Regitz E, Seidel F, Kindermann I, Lohse S, Kos I, Tschöpe C, Kheiroddin P, Kiblboeck D, Hoffmann MC, Bette B, Carbon G, Cetin O, Preuss KD, Christofyllakis K, Bittenbring JT, Pickardt T, Fischer Y, Thiele H, Baldus S, Stangl K, Steiner S, Gietzen F, Kerber S, Deneke T, Jellinghaus S, Linke A, Ibrahim K, Grabmaier U, Massberg S, Thilo C, Greulich S, Gawaz M, Mayatepek E, Meyer-Dobkowitz L, Kindermann M, Birk E, Birk M, Lainscak M, Foell D, Lepper PM, Bals R, Krawczyk M, Mevorach D, Hasin T, Keren A, Kabesch M, Abdul-Khaliq H, Smola S, Bewarder M, Thurner B, Böhm M, Pfeifer J, Klingel K. Thurner L, et al. Among authors: bittenbring jt, bewarder m. N Engl J Med. 2022 Oct 20;387(16):1524-1527. doi: 10.1056/NEJMc2205667. Epub 2022 Sep 21. N Engl J Med. 2022. PMID: 36130012 Free PMC article. No abstract available.
Preclinical Evaluation of a New ECCO2R Setup.
Schwärzel LS, Jungmann AM, Schmoll N, Caspari S, Seiler F, Muellenbach RM, Bewarder M, Thai Dinh Q, Bals R, Lepper PM, Omlor AJ. Schwärzel LS, et al. Among authors: bewarder m. ASAIO J. 2022 Sep 1;68(9):1197-1203. doi: 10.1097/MAT.0000000000001638. Epub 2021 Dec 1. ASAIO J. 2022. PMID: 36066356
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens.
Bock T, Bewarder M, Cetin O, Fadle N, Regitz E, Schwarz EC, Held J, Roth S, Lohse S, Pfuhl T, Wagener R, Smola S, Becker SL, Bohle RM, Trümper L, Siebert R, Hansmann ML, Pfreundschuh M, Drexler HG, Hoth M, Kubuschok B, Roemer K, Preuss KD, Hartmann S, Thurner L. Bock T, et al. Among authors: bewarder m, thurner l. EJHaem. 2022 Jun 16;3(3):739-747. doi: 10.1002/jha2.475. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051037 Free PMC article.
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2.
Kos IA, Kiefer M, Brill K, Cetin O, Bittenbring JT, Ahlgrimm M, Smola S, Lohse S, Christofyllakis K, Kaddu-Mulindwa D, Neumann F, Bewarder M, Thurner L. Kos IA, et al. Among authors: bittenbring jt, bewarder m, thurner l. Expert Rev Vaccines. 2022 Nov;21(11):1683-1689. doi: 10.1080/14760584.2022.2116009. Epub 2022 Aug 26. Expert Rev Vaccines. 2022. PMID: 35994606
IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma.
Struckmeier AK, Radermacher A, Fehrenz M, Bellin T, Alansary D, Wartenberg P, Boehm U, Wagner M, Scheller A, Hess J, Moratin J, Freudlsperger C, Hoffmann J, Thurner L, Roemer K, Freier K, Horn D. Struckmeier AK, et al. Among authors: thurner l. J Cancer Res Clin Oncol. 2023 Jul;149(7):3623-3635. doi: 10.1007/s00432-022-04277-7. Epub 2022 Aug 13. J Cancer Res Clin Oncol. 2023. PMID: 35963900 Free PMC article.
Comparison of immersive and non-immersive virtual reality videos as substitute for in-hospital teaching during coronavirus lockdown: a survey with graduate medical students in Germany.
Omlor AJ, Schwärzel LS, Bewarder M, Casper M, Damm E, Danziger G, Mahfoud F, Rentz K, Sester U, Bals R, Lepper PM. Omlor AJ, et al. Among authors: bewarder m. Med Educ Online. 2022 Dec;27(1):2101417. doi: 10.1080/10872981.2022.2101417. Med Educ Online. 2022. PMID: 35850619 Free PMC article.
Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective study.
Neuchel C, Gowdavally S, Tsamadou C, Platzbecker U, Sala E, Wagner-Drouet E, Valerius T, Kröger N, Wulf G, Einsele H, Thurner L, Schaefer-Eckart K, Freitag S, Casper J, Dürholt M, Kaufmann M, Hertenstein B, Klein S, Ringhoffer M, Frank S, Amann EM, Rode I, Schrezenmeier H, Mytilineos J, Fürst D. Neuchel C, et al. Among authors: thurner l. HLA. 2022 Oct;100(4):349-360. doi: 10.1111/tan.14733. Epub 2022 Jul 27. HLA. 2022. PMID: 35799419
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Celico C, Falautano M, Nonis A, La Rosée P, Binder M, Fabbri A, Ilariucci F, Krampera M, Roth A, Hemmaway C, Johnson PW, Linton KM, Pukrop T, Gørløv JS, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Zanni M, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Thurner L, Cabras G, Pennese E, Ponzoni M, Deckert M, Politi LS, Finke J, Ferranti A, Cozens K, Burger E, Ielmini N, Cavalli F, Zucca E, Illerhaus G; IELSG32 study investigators. Ferreri AJM, et al. Among authors: thurner l. Leukemia. 2022 Jul;36(7):1870-1878. doi: 10.1038/s41375-022-01582-5. Epub 2022 May 13. Leukemia. 2022. PMID: 35562406 Clinical Trial.
Cytotoxic Efficiency of Human CD8+ T Cell Memory Subtypes.
Knörck A, Schäfer G, Alansary D, Richter J, Thurner L, Hoth M, Schwarz EC. Knörck A, et al. Among authors: thurner l. Front Immunol. 2022 Apr 13;13:838484. doi: 10.3389/fimmu.2022.838484. eCollection 2022. Front Immunol. 2022. PMID: 35493468 Free PMC article.
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.
Pfeifer J, Thurner B, Kessel C, Fadle N, Kheiroddin P, Regitz E, Hoffmann MC, Kos IA, Preuss KD, Fischer Y, Roemer K, Lohse S, Heyne K, Detemple MC, Fedlmeier M, Juenger H, Sauer H, Meyer S, Rohrer T, Wittkowski H, Becker SL, Masjosthusmann K, Bals R, Gerling S, Smola S, Bewarder M, Birk E, Keren A, Böhm M, Jakob A, Abdul-Khaliq H, Anton J, Kabesch M, Pino-Ramirez RM, Foell D, Thurner L. Pfeifer J, et al. Among authors: bewarder m, thurner l. Lancet Rheumatol. 2022 May;4(5):e329-e337. doi: 10.1016/S2665-9913(22)00064-9. Epub 2022 Mar 29. Lancet Rheumatol. 2022. PMID: 35368387 Free PMC article.
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group.
Schaffrath J, Brummer C, Wolff D, Holtick U, Kröger N, Bornhäuser M, Kraus S, Hilgendorf I, Blau IW, Penack O, Wittke C, Steiner N, Nachbaur D, Thurner L, Hindahl H, Zeiser R, Maier CP, Bethge W, Müller LP. Schaffrath J, et al. Among authors: thurner l. Transplant Cell Ther. 2022 Jun;28(6):337.e1-337.e10. doi: 10.1016/j.jtct.2022.03.010. Epub 2022 Mar 13. Transplant Cell Ther. 2022. PMID: 35296445 Free PMC article.
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials.
Kaddu-Mulindwa D, Altmann B, Robrecht S, Ziepert M, Regitz E, Tausch E, Held G, Poeschel V, Lesan V, Bittenbring JT, Thurner L, Pfreundschuh M, Christofyllakis K, Truemper L, Loeffler M, Schmitz N, Hoth M, Hallek M, Fischer K, Stilgenbauer S, Bewarder M, Rixecker TM. Kaddu-Mulindwa D, et al. Among authors: bittenbring jt, bewarder m, thurner l. Lancet Haematol. 2022 Feb;9(2):e133-e142. doi: 10.1016/S2352-3026(21)00369-0. Lancet Haematol. 2022. PMID: 35114151 Clinical Trial.
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
Kaddu-Mulindwa D, Gödel P, Kutsch N, Heger JM, Scheid C, Borchmann P, Holtick U, Held G, Thurner L, Bewarder M, Rixecker T, Bittenbring JT. Kaddu-Mulindwa D, et al. Among authors: bittenbring jt, bewarder m, thurner l. Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):e498-e506. doi: 10.1016/j.clml.2022.01.007. Epub 2022 Jan 13. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35094950 Review.
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
Houot R, Poeschel V, Altmann B, Angel S, Thurner L, Illmer T, Andre M, Dreyling M, Maisonneuve H, Tilly H, Mayer S, Casasnovas O, Le Gouill S, Offner F, Cartron G, Kerkhoff A, Weber T, Hoffmann J, Ziepert M, Klapper W, Itti E, Hellwig D, Natchkebia G, de Leval L, Rosenwald A, Haioun C, Dercle L, Gaulard P, Held G. Houot R, et al. Among authors: thurner l. Hemasphere. 2022 Jan 10;6(2):e672. doi: 10.1097/HS9.0000000000000672. eCollection 2022 Feb. Hemasphere. 2022. PMID: 35028526 Free PMC article.
Epigastric Pain After COVID-19 Vaccination.
Casper M, Thurner L, Holz R, Krawczyk M, Link A. Casper M, et al. Among authors: thurner l. Am J Gastroenterol. 2022 Mar 1;117(3):371. doi: 10.14309/ajg.0000000000001609. Am J Gastroenterol. 2022. PMID: 35020675 No abstract available.
Advances in Lymphoma Molecular Diagnostics.
Kos IA, Thurner L, Bittenbring JT, Christofyllakis K, Kaddu-Mulindwa D. Kos IA, et al. Among authors: bittenbring jt, thurner l. Diagnostics (Basel). 2021 Nov 23;11(12):2174. doi: 10.3390/diagnostics11122174. Diagnostics (Basel). 2021. PMID: 34943410 Free PMC article. Review.
Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review).
Christofyllakis K, Bittenbring JT, Thurner L, Ahlgrimm M, Stilgenbauer S, Bewarder M, Kaddu-Mulindwa D. Christofyllakis K, et al. Among authors: bittenbring jt, bewarder m, thurner l. Mol Clin Oncol. 2022 Jan;16(1):21. doi: 10.3892/mco.2021.2453. Epub 2021 Nov 25. Mol Clin Oncol. 2022. PMID: 34909199 Free PMC article. Review.
IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
Kaddu-Mulindwa D, Keuser L, Lesan V, Rissland J, Smola S, Werdecker V, Stilgenbauer S, Christofyllakis K, Thurner L, Bewarder M, Lohr B, Lutz J, Lohse S, Rieke A. Kaddu-Mulindwa D, et al. Among authors: bewarder m, thurner l. HIV Med. 2022 May;23(5):564-569. doi: 10.1111/hiv.13207. Epub 2021 Nov 22. HIV Med. 2022. PMID: 34811869 Free PMC article.
Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
Sabet A, Mader N, Bittenbring JT, Khreish F, Grünwald F, Biersack HJ, Ezziddin S. Sabet A, et al. Among authors: bittenbring jt. Pharmaceuticals (Basel). 2021 Oct 5;14(10):1022. doi: 10.3390/ph14101022. Pharmaceuticals (Basel). 2021. PMID: 34681247 Free PMC article.
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas.
Hartmann S, Scharf S, Steiner Y, Loth AG, Donnadieu E, Flinner N, Poeschel V, Angel S, Bewarder M, Bein J, Brunnberg U, Bozzato A, Schick B, Stilgenbauer S, Bohle RM, Thurner L, Hansmann ML. Hartmann S, et al. Among authors: bewarder m, thurner l. Cancers (Basel). 2021 Oct 17;13(20):5208. doi: 10.3390/cancers13205208. Cancers (Basel). 2021. PMID: 34680356 Free PMC article.
Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial.
Kaddu-Mulindwa D, Lesan V, Berdel C, Stilgenbauer S, Bewarder M, Thurner L, Witzens-Harig M, Viardot A, Soekler M, Keller U, Truemper L, Christofyllakis K, Fleser O, Bittenbring JT, Poeschel V, Held G, Jagoda P. Kaddu-Mulindwa D, et al. Among authors: bittenbring jt, bewarder m, thurner l. Leuk Lymphoma. 2022 Feb;63(2):326-334. doi: 10.1080/10428194.2021.1975193. Epub 2021 Oct 20. Leuk Lymphoma. 2022. PMID: 34668817
Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019.
Lesan V, Bewarder M, Metz C, Becker A, Mang S, Regitz E, Thurner L, Neumann F, Kos I, Christofyllakis K, Danziger G, Stilgenbauer S, Bals R, Lepper PM, Kaddu-Mulindwa D, Rixecker T. Lesan V, et al. Among authors: bewarder m, thurner l. Intensive Care Med Exp. 2021 Sep 3;9(1):45. doi: 10.1186/s40635-021-00409-4. Intensive Care Med Exp. 2021. PMID: 34476598 Free PMC article.
[Conjunctival mantle cell lymphoma-a therapeutic challenge].
Trouvain AM, Bocqué C, Müller LJ, Heinrich C, Bewarder M, Pérez Guerra N, Szurman G, Becker SL, Rickmann A. Trouvain AM, et al. Among authors: bewarder m. Ophthalmologie. 2022 Aug;119(8):837-840. doi: 10.1007/s00347-021-01462-w. Epub 2021 Jul 28. Ophthalmologie. 2022. PMID: 34319474 German. No abstract available.
The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells.
Bewarder M, Kiefer M, Will H, Olesch K, Moelle C, Stilgenbauer S, Christofyllakis K, Kaddu-Mulindwa D, Bittenbring JT, Fadle N, Regitz E, Kaschek L, Hoth M, Neumann F, Preuss KD, Pfreundschuh M, Thurner L. Bewarder M, et al. Among authors: bittenbring jt, thurner l. Hemasphere. 2021 Jul 13;5(8):e620. doi: 10.1097/HS9.0000000000000620. eCollection 2021 Aug. Hemasphere. 2021. PMID: 34263144 Free PMC article.
Current Treatment Options in CLL.
Bewarder M, Stilgenbauer S, Thurner L, Kaddu-Mulindwa D. Bewarder M, et al. Among authors: thurner l. Cancers (Basel). 2021 May 19;13(10):2468. doi: 10.3390/cancers13102468. Cancers (Basel). 2021. PMID: 34069354 Free PMC article. Review.
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
Kaddu-Mulindwa D, Altmann B, Held G, Angel S, Stilgenbauer S, Thurner L, Bewarder M, Schwier M, Pfreundschuh M, Löffler M, Menhart K, Grosse J, Ziepert M, Herrmann K, Dührsen U, Hüttmann A, Barbato F, Poeschel V, Hellwig D. Kaddu-Mulindwa D, et al. Among authors: bewarder m, thurner l. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3550-3559. doi: 10.1007/s00259-021-05348-6. Epub 2021 Apr 29. Eur J Nucl Med Mol Imaging. 2021. PMID: 33928400 Free PMC article.
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
Kos I, Balensiefer B, Lesan V, Kaddu-Mulindwa D, Thurner L, Christofyllakis K, Bittenbring JT, Ahlgrimm M, Seiffert M, Wagenpfeil S, Bewarder Y, Neumann F, Rixecker T, Smola S, Link A, Krawczyk M, Lammert F, Lepper PM, Bals R, Stilgenbauer S, Bewarder M. Kos I, et al. Among authors: bittenbring jt, bewarder m, thurner l. Eur J Immunol. 2021 Jun;51(6):1449-1460. doi: 10.1002/eji.202049163. Epub 2021 Apr 19. Eur J Immunol. 2021. PMID: 33788264 Free PMC article. Clinical Trial.
Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-Analysis.
Christofyllakis K, Pföhler C, Bewarder M, Müller CSL, Thurner L, Rixecker T, Vogt T, Stilgenbauer S, Yordanova K, Kaddu-Mulindwa D. Christofyllakis K, et al. Among authors: bewarder m, thurner l. Front Oncol. 2021 Feb 18;10:637161. doi: 10.3389/fonc.2020.637161. eCollection 2020. Front Oncol. 2021. PMID: 33680957 Free PMC article.
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
Thurner L, Fadle N, Bittenbring JT, Regitz E, Schuck R, Cetin O, Stuhr A, Rixecker T, Murawski N, Poeschel V, Kaddu-Mulindwa D, Preuss KD, Stilgenbauer S, Hermine O, Kluin-Nelemans HC, Hartmann S, Dreyling M, Pott C, Bewarder M, Hoster E. Thurner L, et al. Among authors: bittenbring jt, bewarder m. Blood. 2021 Jun 10;137(23):3251-3258. doi: 10.1182/blood.2020008835. Blood. 2021. PMID: 33513604 Free PMC article. Clinical Trial.
Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition.
Thurner L, Bewarder M, Rosar F, Orth P, Meuter RB, Rixecker T, Lesan V, Kohn DM, Schneider G, Baumhoer D, Bohle RM, Veith C, Bittenbring JT. Thurner L, et al. Among authors: bittenbring jt, bewarder m. Hemasphere. 2020 Dec 9;5(1):e511. doi: 10.1097/HS9.0000000000000511. eCollection 2021 Jan. Hemasphere. 2020. PMID: 33324955 Free PMC article. No abstract available.
Application and clinical impact of the RESIST-4 O.K.N.V. rapid diagnostic test for carbapenemase detection in blood cultures and clinical samples.
Roth S, Berger FK, Link A, Nimmesgern A, Lepper PM, Murawski N, Bittenbring JT, Becker SL. Roth S, et al. Among authors: bittenbring jt. Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):423-428. doi: 10.1007/s10096-020-04021-4. Epub 2020 Sep 7. Eur J Clin Microbiol Infect Dis. 2021. PMID: 32895756 Free PMC article.
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy.
Rixecker T, Lesan V, Ahlgrimm M, Thurner L, Bewarder M, Murawski N, Christofyllakis K, Altmeyer S, Bick A, Stilgenbauer S, Bittenbring JT, Kaddu-Mulindwa D. Rixecker T, et al. Among authors: bittenbring jt, bewarder m, thurner l. Bone Marrow Transplant. 2021 Jan;56(1):195-201. doi: 10.1038/s41409-020-01003-0. Epub 2020 Jul 23. Bone Marrow Transplant. 2021. PMID: 32704092
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Thurner L, Hartmann S, Bewarder M, Fadle N, Regitz E, Schormann C, Quiroga N, Kemele M, Klapper W, Rosenwald A, Trümper L, Bohle RM, Nimmesgern A, Körbel C, Lascke MW, Menger MD, Barth S, Kubuschok B, Mottok A, Kaddu-Mulindwa D, Hansmann ML, Pöschel V, Held G, Murawski N, Stilgenbauer S, Neumann F, Preuss KD, Pfreundschuh M. Thurner L, et al. Among authors: bewarder m. Haematologica. 2021 Aug 1;106(8):2224-2232. doi: 10.3324/haematol.2019.241653. Haematologica. 2021. PMID: 32675228 Free PMC article.